Impact of a training course on the quality of malaria diagnosis by microscopy in Angola

Authors: Bernardino L, Brito M, Fançony C, Fortes F, Mirante C, Moura S, Neves M, Sambo MR
Publication Year: 2014
Journal: Malaria Journal
Link: http://www.malariajournal.com/content/13/1/437

This study was implemented in laboratories from three hospitals in different provinces of Angola: Bengo, Benguela and Luanda. In each laboratory samples were collected before and after the training course (slide with thin and thick blood smears, a dried blood spot and a form).
Read More

Clinical and virological response to antiretroviral drugs among HIV patients on first-line treatment in Dar-es-Salaam, Tanzania

Authors: Kasubi M, Ledwaba J, Morris L, Mosha F, Ndugulile F, Ng’ang’a Z, Nsubuga P, Swai A, Vandamme AM, Vercauteren J
Publication Year: 2014
Journal: The Journal of Infection in Developing Countries
Link: http://www.ncbi.nlm.nih.gov/pubmed/25022294

In Tanzania, the follow-up on antiretroviral therapy (ART) response is based on clinical outcomes. We investigated virological response and ARV resistance mutations in relation to clinical response in ARV-treated patients.
Read More

Where does fear lead us: antiretroviral treatment adherence in Maputo

Authors: Cabral A, Gaspar de Matos M, Moreno M
Publication Year: 2014
Journal: Health
Link: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=43914

This research aims to deepen knowledge on the role of fear on ART adherence of patients who live in Maputo district in Mozambique, including differences on age, gender and schooling level, on their previous knowledge about HIV and ART and on the impact of the discrimination experiences on the ART adherence.
Read More

CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis

Authors: Alvarez C, Brassat D, Decanine D, Galvão-Castro B, Gotuzzo E, Khouri R, Kruschewsky R, Liblau R, López G, Menezes SM, Schnitman SV, Talledo M, Vandamme AM, Weyenbergh JV
Publication Year: 2014
Journal: Journal of Neuroinflammation
Link: http://www.jneuroinflammation.com/content/11/1/18

Human T-cell lymphotropic virus (HTLV-1) is the causative agent of the incapacitating, neuroinflammatory disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Currently, there are no disease-modifying therapies with long-term clinical benefits or validated biomarkers for clinical follow-up in HAM/TSP.
Read More

Horizontal gene transfer from human host to HIV-1 reverse transcriptase confers drug resistance and partly compensates for replication deficits

Authors: De Baets G, Dekeersmaeker N, Li G, Megens S, Moutschen M, Rousseau F, Schrooten Y, Schymkowitz J, Vaira D, Van Laethem K, Vandamme AM
Publication Year: 2014
Journal: Virology
Link: http://www.ncbi.nlm.nih.gov/pubmed/24889250

We investigated the origin and the effect of insertion D67D-THGERDLGPA within HIV-1 RT from a patient failing antiviral therapy. The insertion developed within the context of pre-existing NRTI and NNRTI mutations (M41L, L210W, T215Y and N348I).
Read More

« Previous Page
1
…
6
7
8
9
10
…
21
Next Page »

Impact of a training course on the quality of malaria diagnosis by microscopy in Angola

Clinical and virological response to antiretroviral drugs among HIV patients on first-line treatment in Dar-es-Salaam, Tanzania

Where does fear lead us: antiretroviral treatment adherence in Maputo

CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis

Horizontal gene transfer from human host to HIV-1 reverse transcriptase confers drug resistance and partly compensates for replication deficits

About GHTM

Contacts

Funding